U.S. Congress Introduces CBD Bill
After a series of negative reports regarding the cannabidiol (CBD) industry, recent developments have given stakeholders a ray of hope. A December 2019 article on this BLOG discussed the recent Food and Drug Administration (FDA) activities intended to reiterate that CBD is not an approved ingredient for use in foods and dietary supplements,